Review Looks at Management of HTN in Cancer Patients – American College of Cardiology

In the absence of high-quality evidence, individualized monitoring and treatment of hypertension in cancer patients and survivors may be paramount, according to a state-of-the-art review published Dec. 17 in JACC: CardioOncology. Jordana B. Cohen, MD, MSCE, et al., provide a call for action for improved hypertension identification, treatment and control among…

Read the full article here

Related Articles